Document is current
Any future updates will be listed below
-
Authors
Lobentanzer, Sebastian https://orcid.org/0000-0003-3399-6695
Feng, Shaohong
Bruderer, Noah https://orcid.org/0009-0003-0551-2435
Maier, Andreas https://orcid.org/0000-0003-4408-0068
,
Díaz, Adrián G.
Strange, Amy
Ismail, Anis
Kulaga, Anton
Dugourd, Aurelien
Zdrazil, Barbara
Chassagnol, Bastien
Pommier, Cyril
Lucarelli, Daniele
McDonagh, Ellen M.
Verkinderen, Emma
Delgado-Chaves, Fernando M.
Fuellen, Georg
Sonntag, Hannah
Menger, Jonatan
Christiaen, Lionel
Geistlinger, Ludwig
Zetsche, Luna Zacharias
Engelke, Marlis
McNutt, Megan
Harrison, Melissa
Hizli, Melissa
Usanov, Nikolai
Baracho, Patrick
Beier, Sebastian
Boeing, Stefan
Muranen, Taru A.
Le, Trang T.
Dragan, Valeriia
Zhou, Xiao-Ran
Nielsen-Tehranchian, Yasmin
Song, Yuyao
Wang, Cankun
Baumbach, Jan https://orcid.org/0000-0002-0282-0462
Abreu-Vicente, Jorge https://orcid.org/0000-0002-0211-6416
Krehl, Nils https://orcid.org/0009-0003-1780-6123
Ma, Qin https://orcid.org/0000-0002-3264-8392
Lemberger, Thomas
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
- License Information
-
More Information
Article History
First Online: 22 January 2025
Competing interests
: J.S.-R. reports funding from GSK, Pfizer and Sanofi and fees or honoraria from Travere Therapeutics, Stadapharm, Pfizer, Grunenthal, Owkin, Moderna and Astex Pharmaceuticals.
